SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

Mixed oncology-trial results are driving attention: traders cite BioNTechs BNT113 setback and modest breast-cancer benefit, while bulls point to other promising pipeline readouts and upcoming updates. Debate also reflects concern over the leadership transition and the time needed to turn the pipeline into commercial products.

Twilio, Inc. engages in the development of communications software, cloud-based platforms, and services. It operates through Twilio Communications and Twilio Segments. The Twilio Communications segment includes the platforms Messaging and Voice. The Twilio Segment involves Segment, Engage, Flex, Email, and others. The company was founded by John Wolthuis, Jeffery G. Lawson, and Evan Cooke in March 2008 and is headquartered in San Francisco, CA.

Twilio Inc - Ordinary Shares Class A

Twilio Inc

Twilios quarterly results beat expectations and lifted its full-year outlook, but a softer next-quarter organic growth forecast signaled deceleration and drove a sharp selloff. Traders are debating whether slowing messaging growth and weaker customer expansion outweigh the strong results, while some see the pullback as a potential bounce opportunity.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

SCHD is drawing attention as traders discuss a shift from volatile technology and growth stocks toward dividend-paying value and defensive holdings amid market uncertainty. Many point to its recent strength and keep accumulating, while others question its yield and warn that rising Treasury yields or a return to tech could weigh on the fund.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Traders are focused on whether Q3 results will show that oral Wegovy demand and international expansion can offset concerns about Eli Lillys competitive lead in GLP-1 drugs. The community is divided: some see the pill rollout and low valuation as recovery potential, while others remain cautious about Novos execution, management and pipeline; the Hengrui licensing deal also drew debate as a longer-term pipeline move.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A sharp breakout to a fresh 52-week high has put TGTX in focus, with traders pointing to BRIUMVIs commercial growth and anticipation of earnings and upcoming subcutaneous data. Buyout and short-squeeze theories are circulating, but remain speculation; others see the rally as momentum ahead of those catalysts.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvanas Q3 report, with record sales and revenue growth but an EPS miss and weaker margins, sparked a sharp rally and renewed short-squeeze speculation; traders are also citing the SECs decision to close its investigation without recommending enforcement. The move has drawn competing views, with bulls focused on growth and squeeze potential while bears question profitability, guidance and valuation.

Almonty Industries, Inc. engages in the mining, processing, and shipment of tungsten concentrates. Its projects include Almonty Korea Tungsten, Panasquiera mine, Gentung, Almonty Korea Moly, Los Santos mine, and Valtreixal. The company was founded on September 28, 2009 and is headquartered in Dillon, MT.

Almonty Industries Inc

A sharp selloff and persistent volatility dominate discussion, with traders pointing to broader weakness in miners and uncertainty over Sangdongs production ramp and near-term cash flows. Some remain bullish on tungsten-market fundamentals and the mines first shipment, while others say the investor-day discussion offered little new detail and are concerned about execution.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons strong third-quarter earnings, supported by growth in Dupixent and Eylea HD, sparked a sharp share-price surge and a new 52-week high. Traders are broadly bullish on the breakout, while debating whether the move can hold or will retrace.

Crown Castle, Inc. engages in the business of owning, operating, and leasing shared communications infrastructure. It operates through the following segments: Towers, Fiber, and Other. The Towers segment focuses on providing coverage and capacity for wireless carrier network deployments. The Fiber segment includes communications infrastructure offerings of small cells and fiber solutions. The Other segment is involved in corporate assets such as cash and cash equivalents. The company was founded by Ted B. Miller Jr. and Edward C. Hutcheson Jr. in 1994 and is headquartered in Houston, TX.

Crown Castle Inc

Crown Castle International Corp

Reports that SpaceX is in talks to access at least 80,000 U.S. cell sites, including Crown Castles towers, have focused attention on the prospect of a major new leasing customer. Traders see potential tower revenue upside, while skeptics note that no agreement is signed and question whether SpaceXs wireless plans will translate into meaningful demand.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

A steep selloff in Aehr shares is driving discussion as traders debate whether broader AI and semiconductor weakness, valuation concerns and bearish options flow point to more downside or an oversold setup ahead of earnings. Bulls are watching guidance, backlog and potential AI test-system orders, while skeptics question execution and the companys ability to justify its valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers

iSpecimen (NASDAQ:ISPC) stock increased by 22.7% to $1.89 during Tuesday's pre-market session. The company's market cap stands at $3.8 million.
Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards byread more...

Why iSpecimen Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket

iSpecimen surged 27.9% premarket on a $4.5M Foldlab AI asset deal; CEA Industries led gainers, while Focus Universal plunged 51.2%.read more...

12 Health Care Stocks Moving In Friday's After-Market Session

Gainers

iSpecimen (NASDAQ:ISPC) shares increased by 10.4% to $1.7 during Friday's after-market session. The market value of their outstanding shares is at $3.8 million.
Genelux (NASDAQ:GNLX) stock moved upwards byread more...

Why iSpecimen Shares Are Surging On Friday?

iSpecimen Inc (NASDAQ: ISPC) stock is trading higher Friday after announcing a shipping overhaul that slashes transit times by up to 85%.read more...

iSpecimen Slashes Biospecimen Shipping Times by Up to 85%, Streamlining Global Research Supply Chain

iSpecimen (NASDAQ:ISPC) is making a significant operational leap, announcing a revamped logistics model that dramatically reduces the time it takes to deliver human biospecimens to researchers worldwide.

Top Pre-Market Gainers Today — ISPC, WGRX, RAYA Among Stocks That Are Soaring Before The Bell

Equity

President Donald Trump criticized Iran late night on Thursday for reportedly collecting toll from tankers trying to pass through the Strait of Hormuz.

Why Clearsign Technologies Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket

Clearsign Technologies Corp (NASDAQ: CLIR) shares rose 11.3% in pre-market trading after reporting better-than-expected quarterly results. Other gainers include iSpecimen Inc, Wellgistics Health Inc...

iSpecimen Is Trending Overnight Here's Why ISPC Stock Surged 56% In The After-Hours Session

iSpecimen Inc. shares surge over 56% in after-hours trading after announcing faster shipping and expanded European sourcing, despite weak fourth-quarter results.read more...

Nasdaq Microcap Soars After Unveiling AI Tool Designed to Accelerate Medical Research

Artificial intelligence is rapidly transforming the life sciences industry, particularly in areas where speed and precision can dramatically impact research outcomes. From drug discovery to clinical data analysis, AI-powered tools are increasingly helping scientists process vast amounts of information and connect critical research resources faster than ever before. One emerging application is the use of intelligent platforms to streamline access to human biospecimens, an essential component in developing diagnostics, therapies, and medical breakthroughs.Shares of iSpecimen Inc. (NASDAQ: ...

iSpecimen, Inc. is a healthcare organization that engages in procurement of human biospecimen. It collects biofluids, human tissue, hematopoietic stem, and immune cells. The company was founded by Christopher Ianelli in 2009 and is headquartered in Woburn, MA.

iSpecimen Inc

Bullish Sentiment

<ul class="summary-bullets"><li>iSpecimen shares soared more than 69% in Friday’s pre-market session after the company announced a streamlined shipping model that reduces the transit times for biospecimen shipments by up to 85%.</li><li>Wellgistics shares soared nearly 45% pre-market on Friday after the company announced that it had terminated a share settlement agreement with Silverback Capital.</li><li>Erayak Power shares surged 34% pre-market after the company raised $400,000 from the sale of shares of its common stock to investors.</li></ul>U.S. equities edged lower in Friday’s pre-market trade as investors exercised caution amid lingering tensions due to a fragile ceasefire between the United States and Iran.President Donald Trump criticized Iran late night on Thursday for reportedly collecting toll from tankers trying to pass through the Strait of Hormuz, while adding that the country is doing a “very poor job” of allowing the flow of vessels through the waterway.“There are reports that Iran is charging fees to tankers going through the Hormuz Strait — They better not be and, if they are, they better stop now!” President Trump said in a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://truthsocial.com/@realDonaldTrump/posts/116376791555549648">post</a> on Truth Social.<figure class="image"><img src="https://news.stocktwits-cdn.com/Trump_post_jpg_6724b39ad4.webp" alt="President Donald Trump's post on Truth Social" width="570" height="194"><figcaption>President Donald Trump's post on Truth Social | @realDonaldTrump/Truth Social</figcaption></figure>At the time of writing, the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY), which tracks the S&amp;P 500 index, was down 0.01%; the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust ETF</a> (QQQ) fell 0.02%; and the&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust</a> (DIA) declined 0.04%. Retail sentiment on Stocktwits regarding the S&amp;P 500 ETF was in the ‘extremely bearish’ territory.<h2 class="st-heading-2">Here are the top stocks making the biggest moves in Friday’s pre-market trade:</h2><a href="https://stocktwits.com/symbol/ISPC">iSpecimen Inc. (ISPC)</a>iSpecimen shares soared more than 69% in Friday’s pre-market session after the company announced a streamlined shipping model that reduces the transit times for biospecimen shipments by up to 85%.<a href="https://stocktwits.com/symbol/ISPC">ISPC stock</a> is down 50% year-to-date.<a href="https://stocktwits.com/symbol/WGRX">Wellgistics Health Inc. (WGRX)</a>Wellgistics shares soared nearly 45% pre-market on Friday after the company announced that it had terminated a share settlement agreement with Silverback Capital. Prior to the termination, Wellgistics had issued 6.8 million shares to Silverback.<a href="https://stocktwits.com/symbol/WGRX">WGRX stock</a> is down 74% year-to-date.<a href="https://stocktwits.com/symbol/RAYA">Erayak Power Solution Group Inc. (RAYA)</a>Erayak Power shares surged 34% pre-market after the company raised $400,000 from the sale of shares of its common stock to investors.<a href="https://stocktwits.com/symbol/RAYA">RAYA stock</a> is down 88% year-to-date.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-did-stub-stock-sink-to-all-time-low-today/cZJWOLcRIsJ">STUB Stock Sinks To All-Time Low After FTC Reportedly Sues StubHub Over Alleged Deceptive Ticket Pricing Practices</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

On Monday, Deutsche Bank said CAR’s downgrade to ‘Hold’ from ‘Buy' is "purely fundamental in nature"

ISPC, WGRX, RAYA Pre-Market Gainers Today - President Donald Trump criticized Iran late night on Thursday for reportedly collecting toll from tankers trying to pass through the Strait of Hormuz.

ISPC, WGRX, RAYA Among Stocks That Are Soaring Before The Bell

Erayak Power Solution Group Inc

Wellgistics Health Inc.

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$0.8255
Prev Close	$0.7923
Open	$0.845
Dividend Yield	0.00%
50-Day Moving Average	$1.23
Beta	0.95
Avg. Volume	1.41M
PE Ratio	-0.02

52-Week High	$32.96
52-Week Low	$0.753
Market Capitalization	$2.08M
EPS (Annual)	-$91.15
Price to Book	0.72
Revenue Per Employee	$275,571.14

Feed

News

Sentiment

Earnings

Fundamentals

Info

ISPC Fundamentals